Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Platinum × CNS × Clear all

Phase

Status

Completed 9 Recruiting 2 Active not recruiting 2 Unknown 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 7 Gynecologic 4 Gastrointestinal 2 Other solid neoplasm 1 Lymphoid 1 CNS 1

Conditions

Interventions

Temozolomide 18 Magnetic Resonance Spectroscopy 8 Blood Specimen Collection 8 Radiotherapy 7 Cyclophosphamide 6 Bevacizumab 6 AZD 6244 6 pembrolizumab 5 aflutinib 4 fludarabine 3 Specimen Handling 3 Radiation 3 Pemetrexed 3 Biopsy 3 vorasidenib 2 tovorafenib 2 tislelizumab 2 osimertinib 2 fludarabine phosphate 2 dinutuximab 2 Topotecan 2 Surveys and Questionnaires 2 Surgical Procedures, Operative 2 Radiotherapy, Intensity-Modulated 2 Radiosurgery 2 Nivolumab 2 Lomustine 2 Indocyanine Green 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 Craniotomy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07138001 2025-08-22

Phase 2 Clinical Trial of KH617

Chengdu Kanghong Pharmaceutical Group Co., Ltd.

Phase 2 Not yet recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡